Cerebras Shares Surge 18% After Analysts Set $250–$300 Price Targets
CBRS•Cerebras shares jumped 18% to $238 after UBS, Wedbush and Morgan Stanley initiated coverage with buy ratings and price targets of $250 to $300. The stock is down 24% from its May 14 first-day close of $311 but remains nearly 30% above its $185 IPO price.
1. Analysts Launch Coverage
UBS, Wedbush and Morgan Stanley initiated coverage of Cerebras with buy ratings, driving an 18% surge in the stock to $238 as investors react to their bullish outlooks.
2. Divergent Price Targets
UBS assigned the highest price target at $300, Wedbush set its at $270 and Morgan Stanley at $250, reflecting differing assessments of Cerebras's AI chip adoption and growth potential.
3. Post-IPO Trading Volatility
Since pricing its IPO at $185 and opening at $350, Cerebras shares peaked at $386 before settling at $311 on debut. They later dipped to $201, making Monday’s gain part of a 24% drop from the first-day close but sustaining a 30% premium over IPO cost.
